✦ LIBER ✦

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes

✍ Scribed by Abd A. Tahrani; Anthony H. Barnett

Book ID: 107697255
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 879 KB
Volume: 1
Category: Article
ISSN: 1869-6953
DOI: 10.1007/s13300-010-0007-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and potential role of type-2

Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes

✍ Timothy Colin Hardman; Simon William Dubrey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 781 KB

The novel sodium glucose transporter 2 i

The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats

✍ F. R. Macdonald; J. E. Peel; H. B. Jones; R. M. Mayers; L. Westgate; J. M. Whale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 967 KB

Empagliflozin, a novel selective sodium

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors

✍ R. Grempler; L. Thomas; M. Eckhardt; F. Himmelsbach; A. Sauer; D. E. Sharp; R. A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

From history to reality: sodium glucose

From history to reality: sodium glucose co-transporter 2 inhibitors - a novel therapy for type 2 diabetes mellitus

✍ Nair, S ;Joseph, F ;Ewins, D ;Wilding, J ;Goenka, N 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The human kidney has a key role in the regulation of blood glucose predominantly by reabsorption of glucose from the glomerular filtrate via sodium glucose co‐transporter 2 (SGLT‐2) channels. These are expressed in the proximal renal tubules and are blocked by SGLT‐2 inhibitors, which a

CORRIGENDUM: Dapagliflozin, a Novel, Sel

CORRIGENDUM: Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Remogliflozin etabonate, a selective inh

Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients

✍ R. L. Dobbins; R. O’Connor-Semmes; A. Kapur; C. Kapitza; G. Golor; I. Mikoshiba; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB